About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT03996304

Health and Early Life Microbiota

The aim of this cohort is to identify environmental, lifestyle and genetic factors that modify the human intestinal microbiota development during the first years of life, and to identify early microbi...

Lead sponsor: University of Helsinki•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Helsinki

Collaborators

Business Finland
Valio Ltd
Finnish Red Cross Blood Service
DuPont Nutrition and Health
Oriola Corporation
Pikkujätti Medical Centre for Children and Youth

1055 healthy term infants born in 2016-2018 mainly at the capital region of Finland, and their parents. Fecal samples collected from infants and their parents. Electronic questionnaires on a weekly basis during the first 4 months of life, thereafter less frequently. Focus on diet, well-being and health and social manners. At one-year and at two-years comprehensive questionnaires including development and cognition. Parental stress evaluation included.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•General population, singleton pregnancy, at least one parent Finnish speaking
•Willingness and ability of parents to consent for 2 year follow-up involving frequent electronic questionnaires and freezing of faecal samples at home
•Infant born on gestational weeks 37-42 without known congenital defects

Exclusion Criteria

•Preterm birth
•Severe birth defect
•Parents fail to activate the online questionnaires

Related studies

RECRUITINGPhase 2

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency

RECRUITINGPhase 4

Allergy Delabeling in Antibiotic Stewardship - Intervention

NCT07133074 · Beta Lactam Allergy, Hematologic Malignancy

RECRUITINGPhase 3

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

NCT06948214 · Growth Hormone Deficiency (GHD)

Fetal Growth Restriction a Case Control Study

NCT07025031 · Idiopathic Fetal Growth Restriction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 24, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,055

Start dateFeb 2016

Last updatedJun 24, 2019

Condition

Child Development Growth Allergy Overweight Infectious Disease+1 more

Locations shown

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki

Helsinki

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions